Delivery Order SPE2DB24D2208-SPE2DB25FHGRH
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,501.07, is for the delivery of 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a period of performance through June 12, 2024 and is a Firm Fixed Price Delivery Order. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,719.73 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.66, is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $9,171.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets, a medication used to treat ulcerative colitis. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 26, 2025. This award is not associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,284.56 fixed-price delivery order is for the supply of 180 capsules of 400 mg Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of March 19, 2025 and is not designated with any set-aside requirements, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.39 contract is for the delivery of 120-count tablets of the drug mesalamine 1.2 grams, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of October 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,419.32 firm fixed-price delivery order is for the supply of 180 tablets of 800 mg Mesalamine, a medication used to treat certain gastrointestinal conditions. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,935.72 firm fixed-price delivery order is for the supply of Mesalamine 800 mg delayed-release (DR) tablets, a medication used to treat conditions such as ulcerative colitis. The award, which has a completion date of December 4, 2024, is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award, valued at $4,110.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 180-count bottles of 800mg Mesalamine delayed-release tablets, a medication used to treat ulcerative colitis and Crohn's disease. The contract is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,063.86, is for the delivery of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of July 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB25FHGRHDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,517.71 firm fixed-price delivery order is for 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 10/21/24 |